Investor Relations

Investor Relations

Stock Information View Detailed Stock Information

NASDAQ: CERC Cerecor, Inc.
Day Range
52 Week Range

2015 Annual Report

Download Annual Report

Company Overview

Cerecor is a clinical-stage biopharmaceutical company developing innovative drug candidates to make a difference in the lives of patients with neurological and psychiatric disorders. Cerecor is currently pursuing the development of two clinical Phase 2-stage product candidates, CERC-301 and CERC-501; as well as two earlier stage programs.